Lung Cancer Surgery Market Outlook - 2027
Lung cancer surgery is a medical procedure that is conducted in order to teat lung cancer, especially non-small cell lung cancer. Lung cancer is also referred to as lung carcinoma and is a lethal lung tumor. It is attributed with simultaneous multiplication of tumor cells leading in uncontrolled growth of cells in the lung tissues and is malignant in nature. Caused mainly due to excessive growth of the abnormal cancerous cells in lung area and factors such as smoking, passive smoking in few cases, exposure to carcinogenic toxins and gases and others are responsible for increasing risk of this disease. Primary lung cancer is referred to as carcinomas that initiates in the lungs while secondary lung cancer starts in other body parts and eventually reaches lungs. The lung cancer is detected and confirmed with the help of biopsy that is conducted using CT-guidance or bronchoscopy. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery in lung cancer management is dependent on the position and size of tumor.
COVID – 19 scenario analysis:
- Due to the ongoing COVID – 19 pandemic, with more than to four million infections and the economies showing signs of the 2008 financial crisis, COVID-19 has impacted several industries including lung cancer surgery market as well
- Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for worker
- One of the key concerns looming across the lung cancer surgery industry is the lack of optimum manufacturing capacity
- Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to lung cancer surgery has been reduced and this segment have to face negligence subsequently causing negative impact on lung cancer surgery market
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Owing to major driving factors such as increasing prevalence and incidences of lung cancer, rapid growth in geriatric population around the world, and increasing healthcare expenditure, the lung cancer surgery market worldwide is expected to witness significant growth. Furthermore, heavy investment in research laboratories, surge in air pollution levels, increasing smoking habits coupled with favorable reimbursement policies, specifically in developed countries will amplify the progress of the lung cancer surgery market in the coming years. Patients suffering with chronic obstructive pulmonary disease (COPD) host an increasing risk from lung cancer, the growing prevalence of COPD will stimulate the growing demand for lung cancer surgery. Other factors such as genetic inheritance, rising exposure to carcinogenic chemicals such as arsenic, asbestos, tobacco and radiations like UV rays and X-rays increase risks related to cancer. Pertaining to intake of carcinogens substances, genetic inheritance, smoking, results in intensifying chances of lung cancer, which in have a positive impact on the global lung cancer surgery market.
On the other hand, lack of medical expertise, high cost related to lung cancer surgeries, post-surgical adverse effects including pain and dearth of proper penetration of novel therapeutics making them inaccessible for many consumers in the market are few factors that may hamper the growth of this market to a certain extent.
Emerging and untapped markets, including India, Brazil, and China offer immense growth opportunities for major market players. These countries would ensure market development owing to factors like lesser stringent regulatory scenario in place, increasing disposable incomes and low competition.
Technological advance to boost the growth
Owing to surge in global prevalence of lung cancer, there has been notable shift in consumers opting for technologically superior medical systems and solutions. Additionally, technological developments in lung cancer surgery treatment and rising consumer preference towards minimally invasive surgeries would boost the market growth. Advanced surgical equipment and devices offer ease in operation as well as better device versatility in complex medical situations.
For instance, a leading medical device company Medtronic is preparing for introduction of robotic-assisted surgery system, which will features surgical attributes in general, thoracic, urology, colorectal, and bariatric. Similarly, Johnson & Johnson recently launched ECHELON CIRCULAR™ Powered Stapler for surgical interventions target colorectal, thoracic, and gastric surgery segments. Such technological advances would stimulate the growth of global lung cancer surgery market.
Increasing incidences of lung cancer to propel the growth
Rising incidences of cancers and geriatric population are the factors that go hand-in-hand and are on rise since past few decades. As per World Health Organization report, in the year 2012, approximately 1,824,701 deaths were accounted due to lung cancer every year, and these stats are available for only 13% of lung cancer reported cases. The growth of cancers considering the current growth rate is estimated to have around 27.5 million new cancer cases annually by 2040 around the world. This represents an immense increase of 61.7% from the year 2018 and is further estimated to grow in males with an increasing rate of 67.6 comparatively higher than females estimated to increase at a rate of 55.3%. Additionally, lung cancer being 3rd major cause of cancer in the UK, resulting in 13% of new cases of cancer. Similarly in India, approximately 67,795 new reported cancer cases were seen in 2018. Due to high of cancer, and increasing population base suffering with lung cancer, the demand for lung cancer surgery is expected to surge in the near future, thereby augment the market growth.
Key benefits of the report:
- This study presents the analytical depiction of the global lung cancer surgery market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global lung cancer surgery market share.
- The current market is quantitatively analyzed to highlight the global lung cancer surgery market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global lung cancer surgery market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Lung cancer surgery Market research report:
- What are the leading market players active in the lung cancer surgery market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Lung Cancer Surgery Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Surgery |
|
 By End User |
|
 By Region |
|
 Key Market Players | Covidien,, Olympus Corp.,, Trokamed GMBH, Neomend Inc.,, BSD Medical Corp.,, Accuray Inc.,, Ethicon Endo surgery Inc.,, Siemens Healthcare,, Richard Wolf GMBH,, Angiodynamics,, Scanlan International Inc. |
Loading Table Of Content...
